FDA Approves Use Of Gardasil In Boys And Young Men
- 00:09:15
- NewsInfusion
FDA Approves Use Of Gardasil In Boys And Young Men
October, 16, 2009 - Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for use in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11. More on FDA Approval for Gardasil Use in Males
NewsInfusion | October 17, 2009
FDA Advisory Committee Recommends Approval of Gardasil in Males
FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
FDA Approves Expanded Uses for GARDASIL in Preventing Cancer
Previous Page
Next Page
